RD

Rajesh Dutta

Director Designated Partner DIN 07515417
DIN 07515417 First appointment May 2016 Primary industry Real Estate and Construction
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Dutta

Data last updated:

Rajesh Dutta was a Designated Partner at Skyline Ancillaries Llp (2023–2024) and Additional Director at Vida Pharmaceuticals Private Limited (from 2016). The companies operate in Real Estate and Construction.

DIN 07515417
Primary Designation Designated Partner
Industry Real Estate and Construction
First Appointment 11 May 2016
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner07 Aug 20232022Active
Vida Pharmaceuticals Private Limited U52100WB2013PTC196802
Additional Director11 May 20162013₹9.6 Lakh (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vida Pharmaceuticals Private Limited
Skyline Ancillaries Llp
Premium access

Shareholding and investment profile for Rajesh Dutta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Dutta

Rajesh Dutta was first appointed on 11 May 2016 as Additional Director at Vida Pharmaceuticals Private Limited. The most recent appointment on record is 07 Aug 2023 at Skyline Ancillaries Llp.

Rajesh Dutta held 2 earlier board appointments: Skyline Ancillaries Llp (Designated Partner, 07 Aug 2023 to 31 Mar 2024); Vida Pharmaceuticals Private Limited (Additional Director, from 11 May 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available